Zura Bio (ZURA) Cash from Financing Activities (2022 - 2026)

Zura Bio's Cash from Financing Activities history runs 5 years deep, the most recent figure standing at $135.1 million for Q1 2026.

• On a quarterly basis, Cash from Financing Activities rose 2507.04% year-over-year to $135.1 million in Q1 2026; TTM through Mar 2026 was $127.8 million, a 1207.45% increase from a year earlier, with the FY2025 full-year figure at -$2.2 million, down 101.97% from the prior year.
• Cash from Financing Activities improved to $135.1 million in Q1 2026 per ZURA's latest filing, from -$7.3 million in the prior quarter.
• Across five years, Cash from Financing Activities topped out at $135.1 million in Q1 2026 and bottomed at -$7.3 million in Q4 2025.
• The 5-year median for Cash from Financing Activities is $5.1 million (2022), against an average of $21.0 million.
• Across the five-year window, Cash from Financing Activities tumbled 1051.4% in 2023 and surged 2507.04% in 2026, its largest moves.
• Year by year, Cash from Financing Activities stood at $5.1 million in 2022, then sank by 180.4% to -$4.1 million in 2023, then jumped by 79.28% to -$854000.0 in 2024, then plunged by 756.56% to -$7.3 million in 2025, then soared by 1947.2% to $135.1 million in 2026.
• Per Business Quant, the three latest ZURA Cash from Financing Activities figures stand at $135.1 million (Q1 2026), -$7.3 million (Q4 2025), and $3000.0 (Q3 2025).